These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 13249481)

  • 21. Cultivation of poliomyelitis virus in tissue culture. I. Growth of the Lansing strain in human embryonic tissues.
    THICKE JC; DUNCAN D; WOOD W; FRANKLIN AE; RHODES AJ
    Can J Med Sci; 1952 Jun; 30(3):231-45. PubMed ID: 14945014
    [No Abstract]   [Full Text] [Related]  

  • 22. [Neutralization test with Lansing poliomyelitis virus in mice and tissue cultures].
    EGGERS HJ
    Arch Gesamte Virusforsch; 1957; 7(2):136-42. PubMed ID: 13395383
    [No Abstract]   [Full Text] [Related]  

  • 23. The application of tissue cultures to the preparation and assay of viral antibodies.
    ENDERS JF
    Ann N Y Acad Sci; 1954 Nov; 58(7):1072-84. PubMed ID: 14350502
    [No Abstract]   [Full Text] [Related]  

  • 24. Development, persistence, and significance of type 2, poliomyelitis complement-fixing antibody in man.
    CASALS J; OLITSKY PK; SABIN AB
    J Exp Med; 1952 Jul; 96(1):35-53. PubMed ID: 14946327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of poliomyelitis virus types by complement fixation reaction].
    HENNESSEN W; JACOB W; SEICHTER H
    Dtsch Med Wochenschr; 1955 Oct; 80(43):1565-6. PubMed ID: 13270600
    [No Abstract]   [Full Text] [Related]  

  • 26. [Isolation experiments and serological studies with poliomyelitis virus in tissue culture].
    PINTER M; ABRAHAM E; RAVNAY M
    Orv Hetil; 1956 Apr; 97(15):393-7. PubMed ID: 13335208
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of color change of phenol red as the indicator in titrating poliomyelitis virus or its antibody in a tissue-culture system.
    SALK JE; YOUNGNER JS; WARD EN
    Am J Hyg; 1954 Sep; 60(2):214-30. PubMed ID: 13197372
    [No Abstract]   [Full Text] [Related]  

  • 28. Further experiments with the soluble antigen of the MEF1 poliomyelitis virus.
    SELZER G; VAN DEN ENDE M
    J Hyg (Lond); 1956 Mar; 54(1):1-7. PubMed ID: 13319685
    [No Abstract]   [Full Text] [Related]  

  • 29. [Quantitative relationships between antigen concentration and serum titer in poliomyelitis virus neutralization test].
    DREES O; ROHDE B
    Zentralbl Bakteriol Orig; 1956 Jun; 166(2):84-9. PubMed ID: 13353534
    [No Abstract]   [Full Text] [Related]  

  • 30. Complement-fixing antigens of live and inactivated poliovirus. III. Evaluation of a sensitive quantitative procedure for complement fixation.
    HARE JD; WARREN J
    Am J Hyg; 1958 Nov; 68(3):312-21. PubMed ID: 13594931
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolation of virus and the development of neutralizing and complement-fixing antibodies in poliomyelitic patients.
    MELNICK JL
    Ann N Y Acad Sci; 1955 Sep; 61(4):1005-10. PubMed ID: 13340609
    [No Abstract]   [Full Text] [Related]  

  • 32. Failure to demonstrate antibody in feces of monkeys vaccinated with poliomyelitis virus, Lansing strain.
    AINSLIE JD; McCALLUM JL; FRANCIS T
    Proc Soc Exp Biol Med; 1950 Dec; 75(3):699-703. PubMed ID: 14808371
    [No Abstract]   [Full Text] [Related]  

  • 33. The production of antibodies in cotton rats by living and killed poliomyelitis viruses.
    TOBIN JO
    Br J Exp Pathol; 1956 Apr; 37(2):161-7. PubMed ID: 13315891
    [No Abstract]   [Full Text] [Related]  

  • 34. Observations on the complement-fixing antibody response to poliovirus in patients with certain Coxsackie and ECHO virus infections.
    LENNETTE EH; SCHMIDT NJ; MAGOFFIN RL
    J Immunol; 1961 May; 86():552-60. PubMed ID: 13760855
    [No Abstract]   [Full Text] [Related]  

  • 35. Neutralizing antibody to viruses of poliomyelitis in sera of domestic animals.
    BARTELL P; KLEIN M
    Proc Soc Exp Biol Med; 1955 Dec; 90(3):597-601. PubMed ID: 13289848
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence for dissociation of titer of infectious and antigenic activity in a preparation of the Lansing strain of poliomyelitis virus.
    SALK JE; BENNETT BL
    J Immunol; 1951 Feb; 66(2):283-6. PubMed ID: 14814308
    [No Abstract]   [Full Text] [Related]  

  • 37. The growth curve of the Lansing strain of poliomyelitis virus in the central nervous system of the mouse.
    AINSLIE JD
    J Exp Med; 1952 Jan; 95(1):1-7. PubMed ID: 14907955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age incidence and seasonal development of neutralizing antibodies to lansing poliomyelitis virus.
    TURNER TB; HOLLANDER DH; BUCKLEY S; KOKKO UP; WINSOR CP
    Am J Hyg; 1950 Nov; 52(3):323-47. PubMed ID: 14789759
    [No Abstract]   [Full Text] [Related]  

  • 39. The titration of Lansing poliomyelitis virus in HeLa cell cultures.
    SHEFFIELD FW; SMITH W
    Br J Exp Pathol; 1956 Feb; 37(1):5-10. PubMed ID: 13304235
    [No Abstract]   [Full Text] [Related]  

  • 40. Observations on serum from aborigines in the Northern territory of Australia. III. Antibodies against brunhilde (type I) and leon (type III) poliomyelitis viruses.
    STOKES LJ; AMES PG; MILES JA
    Med J Aust; 1955 Sep; 42(12):433-8. PubMed ID: 13264884
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.